Dishman Pharmaceuticals & Chemicals Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dishman Pharmaceuticals & Chemicals Limited with three other
companies in this sector in India:
Unichem Laboratories Limited
sales of 13.35 billion Indian Rupees [US$195.65 million]
of which 100%
Shilpa Medicare Limited
(7.19 billion Indian Rupees [US$105.46 million]
of which 88%
was Bulk Drugs), and
J B Chemicals and Pharmaceuticals Ltd
(12.40 billion Indian Rupees [US$181.80 million]
of which 100%
Dishman Pharmaceuticals & Chemicals Limited reported sales of 15.96 billion Indian Rupees (US$233.98 million)
March of 2016.
a very small
increase of 1.3%
versus 2015, when the company's sales were 15.75 billion Indian Rupees.
Sales at Dishman Pharmaceuticals & Chemicals Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 61%).
Sales of Crams saw an increase
that was more than double the company's growth rate: sales were up
3.8% in 2016, from
11.01 billion Indian Rupees to 11.42 billion Indian Rupees.
Not all segments of Dishman Pharmaceuticals & Chemicals Limited experienced an increase in sales in 2016:
sales of Bulk Drugs/speciality Chemicals and Others fell 4.4% to 4.54 billion Indian Rupees.